Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.58 |
| ▸ | RAB9A | P51151 | 9/20 | 0.58 |
| ▸ | AR | P10275 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30938000 | 1.00 | NPC1 (0.58) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL7913486 | 0.90 | RAB9A (0.65) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL19227053 | 0.88 | RAB9A (0.56) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL20127212 | 0.85 | NPC1 (0.53) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL21133668 | 0.85 | NPC1 (0.58) | NPC1RAB9ACYP1A2CYP2C19MEN1 | |
| SCHEMBL24621710 | 0.84 | ALDH1A1 (0.46) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL21390594 | 0.84 | NPC1 (0.45) | NPC1RAB9AARCYP3A4CYP1A2 | |
| SCHEMBL21481208 | 0.84 | ALDH1A1 (0.49) | NPC1RAB9ACYP1A2CYP2C19MEN1 | |
| SCHEMBL9838799 | 0.84 | ALDH1A1 (0.52) | NPC1RAB9ACYP3A4CYP1A2CYP2C19 | |
| SCHEMBL31121089 | 0.84 | ALDH1A1 (0.52) | NPC1RAB9ACYP3A4CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710662-B | Heterocyclic compound and organic light-emitting device including the same | LT素材株式会社 | 2024-06-18 | — | — | CN | disclosed |
| US-20220165962-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | LT MATERIALS CO., LTD. (KR) | 2022-05-26 | — | — | US | disclosed |
| US-20220165962-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | LT MATERIALS CO., LTD. (KR) | 2022-05-26 | — | — | US | disclosed |
| CN-113710662-A | Heterocyclic compound and organic light-emitting device including same | LT素材株式会社 | 2021-11-26 | — | — | CN | disclosed |
| WO-2021025356-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | 엘티소재주식회사 | 2021-02-11 | — | — | WO | disclosed |
| EP-0872903-B1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | SHINETSU CHEMICAL CO (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6277519-B1 | QUENCHING AN ALLOY MELT; COMMINUTION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-08-21 | — | — | US | disclosed |
| US-6096144-A | TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-08-01 | — | — | US | disclosed |
| US-5858571-A | TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0355575-B1 | Method of preventing polymer scale formation | SHINETSU CHEMICAL CO (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5298220-A | Forming a coating of a solution containing anioic and cationic dyes and water insoluble organonitrogen compound, drying | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-03-29 | — | — | US | disclosed |
| US-5196164-A | During addition polymerization, wall coating of anionic dye and cationic dye and organonitrogen compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-03-23 | — | — | US | disclosed |
| EP-0355575-A2 | Method of preventing polymer scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1990-02-28 | — | — | EP | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220165962-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CRY1, CYP1A1, CYP1B1 | NPC1 2848/4885RAB9A 2681/4885AR 1942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.